Log in
Enquire now
‌

Augustine Therapeutics

Augustine Therapeutics is a neuromuscular drug developer founded in 2019.

OverviewStructured DataIssuesContributors

Contents

augustinetx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Therapeutics
Therapeutics
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Location
Belgium
Belgium
CEO
Gerhard Koenig
Gerhard Koenig
Number of Employees (Ranges)
11 – 50
Email Address
info@augustinetx.com
Investors
Novo Holdings
Novo Holdings
Newton BioCapital
Newton BioCapital
Gemma Frisius Fund
Gemma Frisius Fund
Jeito Capital
Jeito Capital
Asabys Partners
Asabys Partners
Eli Lilly
Eli Lilly
VIB
VIB
‌
PMV
...
Founded Date
2019
Total Funding Amount (USD)
102,000,000
Latest Funding Round Date
March 24, 2025
Latest Funding Type
Series A
Series A
Country
Belgium
Belgium
Headquarters
Leuven
Leuven

Other attributes

Latest Funding Round Amount (USD)
84,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Augustine Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.